Advertisements
Feeds:
Posts
Comments

Archive for the ‘BioTechnology – Venture Creation’ Category

Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

Posted in BioTechnology - Venture Creation, Cancer Genomics, Conference Coverage with Social Media, CRISPR/Cas9 & Gene Editing, Metabolic Immuno-Oncology, Monoclonal Immunotherapy, Nanotechnology for Drug Delivery on June 17, 2018| Leave a Comment »


Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

 

Advertisements

Read Full Post »

Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

Posted in Artificial Intelligence, BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 12, 2018| Leave a Comment »


Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

Curator: Aviva Lev-Ari, PhD, RN

 

Please review:

  • Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/re-tweets-and-likes-by-pharma_bi-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

  • Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

  • Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL

https://pharmaceuticalintelligence.com/2018/06/11/thriving-at-the-survival-calls-during-careers-in-the-digital-age-an-age-like-no-other-also-known-as-digital/

 

     liked a Tweet you were mentioned in

    4h4 hours ago

             

  2.  14h14 hours ago

    More

    0 replies1 retweet2 likes
    Reply

     

    Retweeted

     1

    Liked

     2

    Direct message

  3.  23h23 hours ago

    More

    Gail Thornton Retweeted @pharma_BI

    From Philip K Dick’s obtuse robots to Mark O’Connell’s guide to transhumanism, novelist Julian Gough picks essential reading for a helter skelter world. Can’t wait to read some of the top 10 books. to survive the digital age!

    Gail Thornton added,

    Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL
    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message

  4.  Jun 11

    More

    Original Tweets by and by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message

  5.  Jun 11

    More

    Re-Tweets and Likes by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your Tweet

    Jun 8

    BRAVO  

    In case you missed Gail Thornton‘s Tweet

    Jun 8

    Bill And Melinda Gates Start A Nonprofit Biotech In Boston via  

  10.  Jun 8

    More

    Gail Thornton Retweeted Aviva Lev-Ari

    Gail Thornton added,

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     Retweeted your Tweet

    Jun 8

    HEROS for cure   
  12.  liked your Tweets

    Jun 8

    HEROS for cure   

    3 other likes

  13.  Jun 8

    More

    BIO 2018 Makes History in Boston – Attendees, Sessions and Videos highlights via

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your Tweet

    Jun 7

     are changing    
     liked your Tweet

    Jun 7

       @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
     liked your Tweet

    Jun 7

    Amazing Conference   
     Retweeted your Tweet

    Jun 7

       
     liked your Tweet

    Jun 7

       

  19.  Jun 7

    More
    Replying to  

    Thanks to Pete Pellerito for keeping the academic zone going . It was great.

     liked your Tweet

    Jun 7

     meets INDUSTRY: BIOTECH & PHARMA with success   
     liked your Tweet

    Jun 7

    BRAVO Scotland in    

  22.  Jun 7

    More
    Replying to   and 2 others

    👊👏🙏

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your reply

    Jun 7

      The Greatest   
     liked your Retweet

    Jun 7

    Standing ovation for Ashanthi De Silva at ! “Have hope, be your own advocate, and never give up.” 
  25.  Retweeted your Retweets

    Jun 6

    Our Biocom team has been taking full advantage of making ALL the connections at ! Check us out at the California Pavilion or stop by Startup Stadium tomorrow where we’ll be supporting our member !

    10 other Retweets

     Retweeted a Tweet you are mentioned in

    Jun 6

         
  27.  liked your Tweets

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

    2 other likes

  28.  Retweeted your Tweet

    Jun 6

        COHORT is assisted by  for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for    can get wrong results by using  

    1 other Retweet

     Retweeted your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
  31.  liked your Retweets

    Jun 6

    Are you at ? Be sure to stop by Booth #2101 to learn more about the 10 remarkable Israeli companies, spanning the spectrum of ’s vigorous Life Sciences community- from innovative start-ups to established companies!

    2 other likes

     Retweeted your Retweet

    Jun 6

    Congrats to  for setting the Guinness World Record for largest business partnering event! 
    ,  and  liked your Tweet

    Jun 6

         only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
     and  liked your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     and  liked your Tweet

    Jun 6

         only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
     liked your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     Retweeted your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     liked your Tweet

    Jun 6

       @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
     liked your Tweet

    Jun 5

    @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     
     and  liked a Tweet you were mentioned in

    Jun 5

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

    Recent Tweet from Gail Thornton

    Jun 5

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

  43.  Jun 5

    More

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC via

    Translate Tweet

    0 replies0 retweets2 likes
    Reply

     

    Retweet

     

    Like

     2

    Direct message
  44.  liked Tweets you were included in

    Jun 5

         

    1 other like

  45.  Jun 5

    More

    0 replies1 retweet1 like
    Reply

     

    Retweet

     1

    Like

     1

    Direct message
  46.  liked your Tweets

    Jun 5

    @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     

    7 other likes

  47.  Jun 5

    More

    0 replies0 retweets1 like
    Reply

     

    Retweet

     

    Like

     1

    Direct message
     liked your Tweet

    Jun 5

    June 4, 2018 –   and , BIO 2018! at Boston BCEC          via 
     Retweeted your Tweet

    Jun 4

     with , MD, President, Novartis Institutes for Biomedical Research (NIBR) !  via 
     Retweeted your reply

    Jun 4

       Novartis Publications #1 collaborator of Pharma-Academia Publish early and Patent late Serial entrepreneur doing research through teams        
     liked your reply

    Jun 4

       Disease areas build the larges  team in the World Killer projects need focus resourced 25 big bets therapeutics lightness RNA splice molecule separating active binders     
     liked your reply

    Jun 4

             finding Drugs? relevant to drug discovery measure phynotype screen relations to molecule – quantify benefits  fatiguability measured  – another tool – data screening optimiz
     liked your reply

    Jun 4

     Vice President, Infectious Diseases & Diagnostics Policy @BIO How DoD can assist Industry to commercialize technologies what coordination in the         
  54.  liked your Tweets

    Jun 4

     (JPM-MCS)          to SKIP a generation        

    1 other like

     liked your Tweet

    Jun 3

    BRAVO MA the  of  
       liked a Tweet you were mentioned in

      5h5 hours ago

               

    3.  12h12 hours ago

      More

      Stanford research sheds light on how species live together via

      https://twitter.com/i/cards/tfw/v1/1006501776340766720?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default342&xdm_p=1
      0 replies0 retweets0 likes
      Reply

       

      Retweet

       

      Like

       

      Direct message

    4.  14h14 hours ago

      More

      0 replies1 retweet2 likes
      Reply

       

      Retweeted

       1

      Liked

       2

      Direct message
       liked your reply

      16h16 hours ago

      Congratulations, till 120, please

    6.  24h24 hours ago

      More

      Gail Thornton Retweeted @pharma_BI

      From Philip K Dick’s obtuse robots to Mark O’Connell’s guide to transhumanism, novelist Julian Gough picks essential reading for a helter skelter world. Can’t wait to read some of the top 10 books. to survive the digital age!

      Gail Thornton added,

      Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL
      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message

    7.  Jun 11

      More

      Original Tweets by and by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message

    8.  Jun 11

      More

      Re-Tweets and Likes by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your Tweet

      Jun 8

      BRAVO  

      In case you missed Gail Thornton‘s Tweet

      Jun 8

      Bill And Melinda Gates Start A Nonprofit Biotech In Boston via  

    13.  Jun 8

      More

      Gail Thornton Retweeted Aviva Lev-Ari

      Gail Thornton added,

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       Retweeted your Tweet

      Jun 8

      HEROS for cure   
    15.  liked your Tweets

      Jun 8

      HEROS for cure   

      3 other likes

    16.  Jun 8

      More

      BIO 2018 Makes History in Boston – Attendees, Sessions and Videos highlights via

      https://twitter.com/i/cards/tfw/v1/1005057826597883904?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default344&xdm_p=1
      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your Tweet

      Jun 7

       are changing    
       liked your Tweet

      Jun 7

         @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
       liked your Tweet

      Jun 7

      Amazing COnference   
       Retweeted your Tweet

      Jun 7

         
       liked your Tweet

      Jun 7

         

    22.  Jun 7

      More
      Replying to  

      Thanks to Pete Pellerito for keeping the academic zone going . It was great.

      0 replies0 retweets0 likes
      Reply

       

      Retweet

       

      Like

       

      Direct message
       liked your Tweet

      Jun 7

       meets INDUSTRY: BIOTECH & PHARMA with success   
       liked your Tweet

      Jun 7

      BRAVO Scotland in    

    25.  Jun 7

      More
      Replying to   and 2 others

      👊👏🙏

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your reply

      Jun 7

        The Greatest   
       liked your Retweet

      Jun 7

      Standing ovation for Ashanthi De Silva at ! “Have hope, be your own advocate, and never give up.” 
    28.  Retweeted your Retweets

      Jun 6

      Our Biocom team has been taking full advantage of making ALL the connections at ! Check us out at the California Pavilion or stop by Startup Stadium tomorrow where we’ll be supporting our member !

      10 other Retweets

       Retweeted a Tweet you are mentioned in

      Jun 6

           
    30.  liked your Tweets

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

      2 other likes

    31.  Retweeted your Tweet

      Jun 6

          COHORT is assisted by  for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for    can get wrong results by using  

      1 other Retweet

       Retweeted your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
    34.  liked your Retweets

      Jun 6

      Are you at ? Be sure to stop by Booth #2101 to learn more about the 10 remarkable Israeli companies, spanning the spectrum of ’s vigorous Life Sciences community- from innovative start-ups to established companies!

      2 other likes

       Retweeted your Retweet

      Jun 6

      Congrats to  for setting the Guinness World Record for largest business partnering event! 
      ,  and  liked your Tweet

      Jun 6

           only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
       and  liked your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       and  liked your Tweet

      Jun 6

           only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
       liked your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       Retweeted your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       liked your Tweet

      Jun 6

         @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
       liked your Tweet

      Jun 5

      @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     
       and  liked a Tweet you were mentioned in

      Jun 5

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

      Recent Tweet from Gail Thornton

      Jun 5

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

    46.  Jun 5

      More

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC via

      Translate Tweet

      https://twitter.com/i/cards/tfw/v1/1004087544664018944?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default345&xdm_p=1
      0 replies0 retweets2 likes
      Reply

       

      Retweet

       

      Like

       2

      Direct message
    47.  liked Tweets you were included in

      Jun 5

           

      1 other like

    48.  Jun 5

      More

      https://twitter.com/i/cards/tfw/v1/1004029288696500224?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default346&xdm_p=1
      0 replies1 retweet1 like
      Reply

       

      Retweet

       1

      Like

       1

      Direct message
    49.  liked your Tweets

      Jun 5

      @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     

      7 other likes

    50.  Jun 5

      More

      https://twitter.com/i/cards/tfw/v1/1004013480746340352?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default347&xdm_p=1
      0 replies0 retweets1 like
      Reply

       

      Retweet

       

      Like

       1

      Direct message
       liked your Tweet

      Jun 5

      June 4, 2018 –   and , BIO 2018! at Boston BCEC          via 
       Retweeted your Tweet

      Jun 4

       with , MD, President, Novartis Institutes for Biomedical Research (NIBR) !  via 
       Retweeted your reply

      Jun 4

         Novartis Publications #1 collaborator of Pharma-Academia Publish early and Patent late Serial entrepreneur doing research through teams        
       liked your reply

      Jun 4

         Disease areas build the larges  team in the World Killer projects need focus resourced 25 big bets therapeutics lightness RNA splice molecule separating active binders     
       liked your reply

      Jun 4

               finding Drugs? relevant to drug discovery measure phynotype screen relations to molecule – quantify benefits  fatiguability measured  – another tool – data screening optimiz
       liked your reply

      Jun 4

       Vice President, Infectious Diseases & Diagnostics Policy @BIO How DoD can assist Industry to commercialize technologies what coordination in the         
    57.  liked your Tweets

      Jun 4

       (JPM-MCS)          to SKIP a generation        

      1 other like

       liked your Tweet

      Jun 3

      BRAVO MA the  of  

Read Full Post »

Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL

Posted in Big Data & Analytics, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceuticall R&D Informatics, Clinical Genomics, Cancer Informatics, BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Data Science, Digital HealthCare – biotech & internet joint ventures, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Law & Patient Safety, HealthCare IT, LPBI Group Founder - Aviva Lev-Ari, Scientific & Biotech Conferences: Press Coverage, Scientific Publishing, Scientist: Career considerations, Statistical Methods for Research Evaluation, Women in Life Sciences on June 11, 2018| Leave a Comment »


Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL

Author and Curator: Aviva Lev-Ari, PhD, RN

 

The source for the inspiration to write this curation is described in

Survival Calls during Careers in the Digital Age

https://pharmaceuticalintelligence.com/2018/06/13/survival-calls-during-careers-in-the-digital-age/

 

In this curation, I present the following concepts in three parts:

  1. Part 1: Authenticity of Careers in the Digital Age: In Focus, the BioTechnology Sector

  2. Part 2: Top 10 books to help you survive the Digital Age

  3. Part 3: A case study on Thriving at the Survival Calls during Careers in the Digital Age: Aviva Lev-Ari, UCB, PhD’83; HUJI, MA’76 

 

Part 1: Authenticity of Careers in the Digital Age: 

In Focus, the BioTechnology Sector

 

Lisa LaMotta, Senior Editor, BioPharma Dive wrote in Conference edition | June 11, 2018

Unlike that little cancer conference in Chicago last week, the BIO International convention is not about data, but about the people who make up the biopharma industry.

The meeting brings together scientists, board members, business development heads and salespeople, from the smallest virtual biotechs to the largest of pharmas. It allows executives at fledgling biotechs to sit at the same tables as major decision-makers in the industry — even if it does look a little bit like speed dating.

But it’s not just a partnering meeting.

This year’s BIO also sought to shine a light on pressing issues facing the industry. Among those tackled included elevating the discussion on gender diversity and how to bring more women to the board level; raising awareness around suicide and the need for more mental health treatments; giving a voice to patient advocacy groups; and highlighting the need for access to treatments in developing nations.

Four days of meetings and panel discussions are unlikely to move the needle for many of these challenges, but debate can be the first step toward progress.

I attended the meetings on June 4,5,6, 2018 and covered in Real Time the sessions I attended. On the link below, Tweets, Re-Tweets and Likes mirrors the feelings and the opinions of the attendees as expressed in real time using the Twitter.com platform. This BioTechnology events manifested the AUTHENTICITY of Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL.

The entire event is covered on twitter.com by the following hash tag and two handles:

 

I covered the events on two tracks via two Twitter handles, each handle has its own followers:

The official LPBI Group Twitter.com account

The Aviva Lev-Ari, PhD, RN Twitter.com account

Track A:

  • Original Tweets by @Pharma_BI and by @AVIVA1950 for #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/06/11/original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

  • Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/06/12/reactions-to-original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018/

Track B:

  • Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/06/11/re-tweets-and-likes-by-pharma_bi-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

Part 2: Top 10 books to help you survive the digital age

From Philip K Dick’s obtuse robots to Mark O’Connell’s guide to transhumanism, novelist Julian Gough picks essential reading for a helter skelter world

Here are 10 of the books that did help me [novelist Julian Gough]: they might also help you understand, and survive, our complicated, stressful, digital age.

  1. Marshall McLuhan Unbound by Marshall McLuhan (2005)
    The visionary Canadian media analyst predicted the internet, and coined the phrase the Global Village, in the early 1960s. His dense, complex, intriguing books explore how changes in technology change us. This book presents his most important essays as 20 slim pamphlets in a handsome, profoundly physical, defiantly non-digital slipcase.
  2. Ubik by Philip K Dick (1969)
    Pure pulp SF pleasure; a deep book disguised as a dumb one. Dick shows us, not a dystopia, but a believably shabby, amusingly human future. The everyman hero, Joe Chip, wakes up and argues with his robot toaster, which refuses to toast until he sticks a coin in the slot. Joe can’t do this, because he’s broke. He then has a stand-up row with his robot front door, which won’t open, because he owes it money too … Technology changes: being human, and broke, doesn’t. Warning: Dick wrote Ubik at speed, on speed. But embedded in the pulpy prose are diamonds of imagery that will stay with you for ever.
  3. The Singularity Is Near by Ray Kurzweil (2005)
    This book is what Silicon Valley has instead of a bible. It’s a visionary work that predicts a technological transformation of the world in our lifetime. Kurzweil argues that computer intelligence will soon outperform human thought. We will then encode our minds, upload them, and become one with our technology, achieving the Singularity. At which point, the curve of technological progress starts to go straight up. Ultimately – omnipotent, no longer mortal, no longer flesh – we transform all the matter in the universe into consciousness; into us.
  4. To Be a Machine by Mark O’Connell (2017)
    This response to Kurzweil won this year’s Wellcome prize. It’s a short, punchy tour of transhumanism: the attempt to meld our minds with machines, to transcend biology and escape death. He meets some of the main players, and many on the fringes, and listens to them, quizzically. It is a deliberately, defiantly human book, operating in that very modern zone between sarcasm and irony, where humans thrive and computers crash.
  5. A Visit from the Goon Squad by Jennifer Egan (2011)
    This intricately structured, incredibly clever novel moves from the 60s right through to a future maybe 15 years from now. It steps so lightly into that future you hardly notice the transition. It has sex and drugs and rock’n’roll, solar farms, social media scams and a stunningly moving chapter written as a PowerPoint presentation. It’s a masterpiece. Life will be like this.
  6. What Technology Wants by Kevin Kelly (2010)
    Kelly argues that we scruffy biological humans are no longer driving technological progress. Instead, the technium, “the greater, global, massively interconnected system of technology vibrating around us”, is now driving its own progress, faster and faster, and we are just caught up in its slipstream. As we accelerate down the technological waterslide, there is no stopping now … Kelly’s vision of the future is scary, but it’s fun, and there is still a place for us in it.
  7. The Meme Machine by Susan Blackmore (1999)
    Blackmore expands powerfully and convincingly on Richard Dawkins’s original concept of the meme. She makes a forceful case that technology, religion, fashion, art and even our personalities are made of memes – ideas that replicate, mutate and thus evolve over time. We are their replicators (if you buy my novel, you’ve replicated its memes); but memes drive our behaviour just as we drive theirs. It’s a fascinating book that will flip your world upside down.
  8. Neuromancer by William Gibson (1984)
    In the early 1980s, Gibson watched kids leaning into the screens as they played arcade games. They wanted to be inside the machines, he realised, and they preferred the games to reality. In this novel, Gibson invented the term cyberspace; sparked the cyberpunk movement (to his chagrin); and vividly imagined the jittery, multi-screened, anxious, technological reality that his book would help call into being.
  9. You Are Not a Gadget: A Manifesto by Jaron Lanier (2010)
    Lanier, an intense, brilliant, dreadlocked artist, musician and computer scientist, helped to develop virtual reality. His influential essay Digital Maoism described early the downsides of online collective action. And he is deeply aware that design choices made by (mainly white, young, male) software engineers can shape human behaviour globally. He argues, urgently, that we need to question those choices, now, because once they are locked in, all of humanity must move along those tracks, and we may not like where they take us. Events since 2010 have proved him right. His manifesto is a passionate argument in favour of the individual voice, the individual gesture.
  10. All About Love: New Visions by bell hooks (2000)
    Not, perhaps, an immediately obvious influence on a near-future techno-thriller in which military drones chase a woman and her son through Las Vegas. But hooks’s magnificent exploration and celebration of love, first published 18 years ago, will be far more useful to us, in our alienated digital future, than the 10,000 books of technobabble published this year. All About Love is an intensely practical roadmap, from where we are now to where we could be. When Naomi and Colt find themselves on the run through a militarised American wilderness of spirit, when GPS fails them, bell hooks is their secret guide.

SOURCE

https://www.theguardian.com/books/2018/may/30/top-10-books-to-help-you-survive-the-digital-age?utm_source=esp&utm_medium=Email&utm_campaign=Bookmarks+-+Collections+2017&utm_term=277690&subid=25658468&CMP=bookmarks_collection

Part 3: A case study on Thriving at the Survival Calls during Careers in the Digital Age:  Aviva Lev-Ari, UCB, PhD’83; HUJI, MA’76

 

On June 10, 2018

 

Following, is a case study about an alumna of HUJI and UC, Berkeley as an inspirational role model. An alumna’s profile in context of dynamic careers in the digital age. It has great timeliness and relevance to graduate students, PhD level at UC Berkeley and beyond, to all other top tier universities in the US and Europe. As presented in the following curations:

Professional Self Re-Invention: From Academia to Industry – Opportunities for PhDs in the Business Sector of the Economy

https://pharmaceuticalintelligence.com/2018/05/22/professional-self-re-invention-from-academia-to-industry-opportunities-for-phds-in-the-business-sector-of-the-economy/

 

Pioneering implementations of analytics to business decision making: contributions to domain knowledge conceptualization, research design, methodology development, data modeling and statistical data analysis: Aviva Lev-Ari, UCB, PhD’83; HUJI, MA’76 

https://pharmaceuticalintelligence.com/2018/05/28/pioneering-implementations-of-analytics-to-business-decision-making-contributions-to-domain-knowledge-conceptualization-research-design-methodology-development-data-modeling-and-statistical-data-a/

 

This alumna is Editor-in-Chief of a Journal that has other 173 articles on Scientist: Career Considerations 

https://pharmaceuticalintelligence.com/category/scientist-career-considerations/

 

In a 5/22/2018 article, Ways to Pursue Science Careers in Business After a PhD by Ankita Gurao,

https://bitesizebio.com/38498/ways-to-pursue-the-business-of-science-after-a-ph-d/?utm_source=facebook&utm_medium=social&utm_campaign=SocialWarfare

Unemployment figures of PhDs by field of science are included, Ankita Gurao identifies the following four alternative careers for PhDs in the non-academic world:

  1. Science Writer/Journalist/Communicator
  2. Science Management
  3. Science Administration
  4. Science Entrepreneurship

My career, as presented in Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

https://pharmaceuticalintelligence.com/2018/03/06/reflections-on-a-four-phase-career-aviva-lev-ari-phd-rn-march-2018/

has the following phases:

  • Phase 1: Research, 1973 – 1983
  • Phase 2: Corporate Applied Research in the US, 1985 – 2005
  • Phase 3: Career Reinvention in Health Care, 2005 – 2012
  • Phase 4: Electronic Scientific Publishing, 4/2012 to present

These four phases are easily mapped to the four alternative careers for PhDs in the non-academic world. One can draw parallel lines between the four career opportunities A,B,C,D, above, and each one of the four phases in my own career.

Namely, I have identified A,B,C,D as early as 1985, and pursued each of them in several institutional settings, as follows:

A. Science Writer/Journalist/Communicator – see link above for Phase 4: Electronic Scientific Publishing, 4/2012 to present 

B. Science Management – see link above for Phase 2: Corporate Applied Research in the US, 1985 – 2005 and Phase 3: Career Reinvention in Health Care, 2005 – 2012 

C. Science Administration – see link above for Phase 2: Corporate Applied Research in the US, 1985 – 2005and Phase 4: Electronic Scientific Publishing, 4/2012 to present 

D. Science Entrepreneurship – see link above for Phase 4: Electronic Scientific Publishing, 4/2012 to present  

Impressions of My Days at Berkeley in Recollections: Part 1 and 2, below.

  • Recollections: Part 1 – My days at Berkeley, 9/1978 – 12/1983 –About my doctoral advisor, Allan Pred, other professors and other peers

https://pharmaceuticalintelligence.com/2018/03/15/recollections-my-days-at-berkeley-9-1978-12-1983-about-my-doctoral-advisor-allan-pred-other-professors-and-other-peer/

  • Recollections: Part 2 – “While Rolling” is preceded by “While Enrolling” Autobiographical Alumna Recollections of Berkeley – Aviva Lev-Ari, PhD’83

https://pharmaceuticalintelligence.com/2018/05/24/recollections-part-2-while-rolling-is-preceded-by-while-enrolling-autobiographical-alumna-recollections-of-berkeley-aviva-lev-ari-phd83/

The topic of Careers in the Digital Age is closely related to my profile, see chiefly: Four-phase Career, Reflections, Recollections Parts 1 & 2 and information from other biographical sources, below.

Other sources for my biography

 

Read Full Post »

Original Tweets by @Pharma_BI and by @AVIVA1950 for #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 11, 2018| Leave a Comment »


Original Tweets by @Pharma_BI and by @AVIVA1950 for #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

 

  1.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ in Cambridge study sensors on patients contact dermatitis patients sensors monitor movement text mining sensation reported by patients with sensors trajectory monitored drug device external partnership

  2.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ new drug: Biotech in Scripps, CA and another in Cambridge, MA and ⁦⁩ as Pharma collaboration with biotech Partnership with UPenn with Duke, NC agility in small co scale in Pharma

  3.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ and Medical community decide on directions for surrogate followed by survival NASH redefine NEW drug innovations will move faster Vaccine for NASH growing obesity population Network for collaboration

  4.  Jun 6

    More

    ⁦⁩ immunicity correlated confirm benefit in based study patient to benefit early on while cost benefit be known later inflammatory indicators across diseases JAKS inhibitors which drug for which patient

  5.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ redefine by genomics clinical trials on patients with Gene expression 150 patients 60% improve rate new drug approved in 2011 in oncology how sustain innovation by cost effective trials? Patient selection

  6.  Jun 6

    More

    ⁦⁩ Mikael Dolsten ⁦⁩ R&D budget for contribution capital allocation focus on deep expertise in multiple drugs in multiple indications Lipitor dependence ends patent expiration

  7.  Jun 6

    More

    only by knowing both one can develop applications in vs questions are the hard part vs expertise needed for structural models type of data collected may not be best

    Like

    3

    View Tweet activity

  8.  Jun 6

    More

  9.  Jun 6

    More

    for idiopathic fibrosis using CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

    1 reply2 retweets3 likes
    Reply

    1

    Retweet

    2

    Like

    3

    View Tweet activity

  10.  Jun 6

    More

    for patients goals apply right approach to care right drug respond to therapy is a HC goal combined with patient goals

  11.  Jun 6

    More

    @FoundationMedicine in 7 days genomic data, clinical data and patient of patient took place in clean data sets are a must for patient total clinical profile

    Retweet

    1

    Like

    3

  12.  Jun 6

    More

    COHORT is assisted by for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for can get wrong results by using

    1 retweet1 like
    Retweet

    1

    Like

    1

  13.  Jun 6

    More

    @FoundationMedicine sequenced 200,000 Cancer patients genome use data to Target positive predicted responders to accelerate clinical trials. use of on genomic data for

  14.  Jun 6

    More

    -based value in leadership is brief the dime

  15.  Jun 6

    More

    #@AVIVA1950 to launch an industry stick initiative

  16.  Jun 6

    More

    2008

  17.  Jun 5

    More

    Breakthrough , June 5, 2018 , Boston, BCEC via

  18.  Jun 5

    More

    -Making and of the : Findings from , June 5, 1:45-2:45PM, BIO 2018!, Boston, BCEC via

  19.  Jun 5

    More

    @KatrineBosley @EditasMedicine Valuation for 23andme? Each pool of capital has different investors been attracted

  20.  Jun 5

    More

    @JohnMaraganore @ALNYLAMPHARMACEUTICALS In 16 years rained $4Billion and expenses $2.5Billion – still not profitable – that what it takes

  21.  Jun 5

    More

    @JeanFrancisFormela Science is extraordinary A lot of capital and very many tech ventures over supply of capital accelerates the business More capital is better, what to invest is critical

  22.  Jun 5

    More

    & , June 5, 11-12, BIO 2018! Boston, BCEC via

  23.  Jun 5

    More

    US is not the only player, CANADA’ universal payer system made major strides lung cancer experienced development of 50 drug base on tumor type predict likelihood drug resistance BR CA patient which not require therapy

  24.  Jun 5

    More

    @RajuKucherlapati Integration of EMR Partners leader missing link is integration of Genomic dat aat the patient level with clinical dat of patients Patients will manage their 23andme data PM is global vs access to care

  25.  Jun 5

    More

    @RajuKucherlapati with million of people with genetic and medical information — searches of profile too group patients for optimal of with DB of – IBM

  26.  Jun 5

    More

    @RajuKucherlapati Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder

    Like

    2

  27.  Jun 5

    More

    Sajeev Kohli (11th Grade, Waterloo, On, Canada)Receives Top Honor at International BioGENEius Challenge Students from California, Washington and Germany named runners-up June 5, 2018 – Boston, Massachusetts –

  28.  Jun 5

    More

    : based Systems, June 5, BIO 2018!, Boston, BCEC via

    1 like

    Like

    1

  29.  Jun 4

    More

    Tales from the – Four Unique Approaches to Turning into via

  30.  Jun 4

    More

    with , MD, President, Novartis Institutes for Biomedical Research (NIBR) ! via

    1 retweet
    Retweet

    1

  31.  Jun 4

    More

    June 4, 2018 – and , BIO 2018! at Boston BCEC via

    2 likes
    Like

    2

  32.  Jun 4

    More

    @TimothyBelski Joint Program Executive Office for Chemical and Biological Defense Manufacturing for DoD Infrastructure to manage across Government RFP Process

  33.  Jun 3

    More

    We cover this event in Real Time

    1 like

    Like

    1

  34.  Jun 3

    More

    Aviva Lev-Ari Retweeted MassBio

    BRAVO MA the of

    Aviva Lev-Ari added,

    It’s no wonder is in Massachusetts next week. Great things are happening here for the economy and for patients.
    1 like

    Like

    1

  35.  Jun 3

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    Interested Chief Scientific Officer

    Aviva Lev-Ari added,

    Mark your calendars! Chief Scientific Officer Paul Stoffels will sit down with founder on Monday at 4pm at to discuss how we can speed innovation in science and…

Read Full Post »

Re-Tweets and Likes by @Pharma_BI @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 11, 2018| Leave a Comment »


Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

 

  1.   Retweeted

     Jun 7

    More

    Aviva Lev-Ari Retweeted Jeff Galvin

    Well put I agree with you, Jeff

    Aviva Lev-Ari added,

    Congratulations for an impactful conference! You brought together the brightest national and international industry minds to advance . I look forward to !
    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    View Tweet activity
  2.   Retweeted

     Jun 7

    More

    Aviva Lev-Ari Retweeted I Am Biotech

    For see

    Aviva Lev-Ari added,

    Understanding the Voice: Unique Perspectives on
    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    View Tweet activity

  3.  Jun 7

    More

    News Release Makes History in  – , and highlights via

    https://twitter.com/i/cards/tfw/v1/1004938263482847234?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5891&xdm_p=1
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  4.  Jun 7

    More

    Aviva Lev-Ari Retweeted Christiane Truelove

    BRAVO FDA in 2018 is AGILE

    Aviva Lev-Ari added,

    RT : Under companies have no obligation to honor requests. But some ppl think they do, and exchanges like this could become more common. …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  5.  Jun 7

    More

    Aviva Lev-Ari Retweeted CCAB

    ASCO weigh in on CAR-Ts versus bispecific antibodies

    Aviva Lev-Ari added,

    Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  6.  Jun 7

    More

    Aviva Lev-Ari Retweeted Dana-Farber News

    Aviva Lev-Ari added,

    Dana-Farber President and CEO Dr. Laurie Glimcher shares her views on the state of , treatment, and care at .
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  7.   Retweeted

     Jun 7

    More

    🇬🇧 has >5600 LifeSci businesses. Find cos w/ solutions for your business in our 🇬🇧 BioPharma asset list

    https://twitter.com/i/cards/tfw/v1/1004763844831563776?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5892&xdm_p=1
    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Liked

    3

    Direct message

  8.  Jun 7

    More

    Aviva Lev-Ari Retweeted Jim Greenwood

    BRAVO inaugural Henri A. Termeer Biotechnology Visionary Award

    Aviva Lev-Ari added,

    It was my pleasure to present with the inaugural Henri A. Termeer Biotechnology Visionary Award.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  9.  Jun 7

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    BRAVO

    Aviva Lev-Ari added,

    LIVE from the session with ‘s who is “looking for communities that are interested about plugging in and being truly ” to foster & to…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  10.   Retweeted

     Jun 7

    More

    The 2018 Bio International Convention has been amazing! This was the view from our water taxi ride to the hotel last night! 🚤🛳🛥⛵️

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message

  11.  Jun 7

    More

    Aviva Lev-Ari Retweeted Ozmosi

    TRUE

    Aviva Lev-Ari added,

    : Depression, Pain Drug Developers Starve for Dollars as Companies Feast
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  12.   Retweeted

     Jun 7

    More

    On this last day of , want to hear from you! What was your favorite part of this year?

    https://twitter.com/i/cards/tfw/v1/1004793829168504833?cardname=poll4choice_text_only&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=184&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5893&xdm_p=1
    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Like

    3

    Direct message

  13.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sanofi US

    BRAVO Sanofi

    Aviva Lev-Ari added,

    Through Sanofi Ventures, the corporate VC arm of Sanofi, we build strong relationships with innovators and entrepreneurs to develop future strategic collaborations and, ultimately, realize cutting-edge treatments for…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  14.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sue Desmond-Hellmann

    HEROS for cure

    Aviva Lev-Ari added,

    This quote from the late Henri Termeer explains why I nearly couldn’t finish my 2 minute acceptance speech for the inaugural Henri A. Termeer Biotech Visionary Award without bursting into tears. ⁦⁩
    0 replies1 retweet1 like
    Reply
    Retweet

    1

    Like

    1

    View Tweet activity

  15.  Jun 7

    More

    Aviva Lev-Ari Retweeted BIO Intl Convention

    BRAVO

    Aviva Lev-Ari added,

    That’s a wrap, folks! Thanks to attendees, exhibitors, sponsors, volunteers, staff members, contractors, and for another record breaking year! We really did MAKE HISTORY and…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  16.  Jun 7

    More

    Aviva Lev-Ari Retweeted Noy Kaufman

    Aviva Lev-Ari added,

    Had such a great time at the  convention in Boston!  Learned so much about entrepreneurship in biotech through the National Science Foundation (NSF) I-CORPS program, Massachusetts Institute of Technology venture mentoring, and UNHInnovation. We co……
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  17.  Jun 7

    More

    Aviva Lev-Ari Retweeted Business Sweden Invest

    Aviva Lev-Ari added,

    Five Swedish hot spots for precision medicine development in Sweden. Find out how you can tap in to the Swedish landscape. Looking for something to bring home from ? Download…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  18.  Jun 7

    More

    Aviva Lev-Ari Retweeted Alaric DeArment

    Aviva Lev-Ari added,

    You’ve heard about the sky-high response rates, but clinical competence and infrastructure remain two big challenges ahead for therapies. …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  19.  Jun 7

    More

    Aviva Lev-Ari Retweeted Mike Huckman

    BRAVO

    Aviva Lev-Ari added,

    Here’s on ways to make progress in the fight against opioid addiction. “Buzz Center” via
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  20.  Jun 7

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    BRAVO

    Aviva Lev-Ari added,

    Congratulations we certainly had a few of those meetings
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  21.  Jun 7

    More

    Aviva Lev-Ari Retweeted Elizabeth Cutler

    Bravo

    Aviva Lev-Ari added,

    If you enjoyed but want more applications for info, come back to Boston in October. Registration is now open:
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  22.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sanofi US

    BRAVO Sanofi, so smart to have bought Genzyme

    Aviva Lev-Ari added,

    Rachel Sha, VP Digital BD & Licensing, during today’s New Tech & Digital Advances for Drug Discovery session: “Big pharma doesn’t typically like to take big risks… We look for partners who are focused on details and…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  23.  Jun 7

    More

    Aviva Lev-Ari Retweeted Biotech Institute

    BRAVO Challenge!

    Aviva Lev-Ari added,

    This video will “Blow your Mind.” Congratulations, Sajeev Kohli for winning then2018 International Challenge!
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  24.  Jun 7

    More

    Aviva Lev-Ari Retweeted IAM Platform

    Aviva Lev-Ari added,

    IAM Platform Curated Retweet: Via: …
    0 replies1 retweet1 like
    Reply
    Retweet

    1

    Like

    1

    View Tweet activity

  25.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sema4

    and at

    Aviva Lev-Ari added,

    Our CEO Dr Eric Schadt discussing how to extract signal from the noise of sets, using and at
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  26.  Jun 7

    More

    Aviva Lev-Ari Retweeted Worldwide Clinical

    are changing

    Aviva Lev-Ari added,

    Take uncommon pics like this using our giveaway. At Booth 2654, you can meet with our experts & hear how our approach can help your .
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  27.  Jun 7

    More

    Aviva Lev-Ari Retweeted Lori Collins

    ‘Largest Business Partnering Event’! Proud to cover the event in

    Aviva Lev-Ari added,

    Yesterday, made history by setting a GUINNESS WORLD RECORD for the ‘Largest Business Partnering Event’!  is proud to be a part of
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  28.  Jun 7

    More

    Aviva Lev-Ari Retweeted Mike Huckman

    BRAVO One HUGE man

    Aviva Lev-Ari added,

    Here’s CEO and Board Chair talking about a big year for his company & at the “Buzz Center” via
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  29.  Jun 7

    More

    Aviva Lev-Ari Retweeted Cleveland Scott York

    45,000 Partening sessions – BRAVO !!

    Aviva Lev-Ari added,

    CSYer Hazel set a world record (with a little help from her friends) by being part of the breaking partnering event that was
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  30.  Jun 7

    More

    Aviva Lev-Ari Retweeted Thermo Fisher G.R.

    BRAVO gravitas

    Aviva Lev-Ari added,

    Congrats & on hosting a wicked great ! That’s a wrap.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  31.  Jun 7

    More

    Aviva Lev-Ari Retweeted The Global IP Center

    KEY in see our

    Aviva Lev-Ari added,

    🔍
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  32.  Jun 7

    More

    Aviva Lev-Ari Retweeted NHS Research Scotland

    BRAVO Scotland in

    Aviva Lev-Ari added,

    Thank you – building and to help make a positive difference to within , the and internationally – thank you for…
    0 replies0 retweets2 likes
    Reply
    Retweet

    Liked

    2

    View Tweet activity

  33.  Jun 7

    More

    Aviva Lev-Ari Retweeted Quanterix

    BRAVO landscape in in light of

    Aviva Lev-Ari added,

    Great segments from on the landscape in in light of . We’re proud to be among the companies helping to further innovation and achievement in the hub!
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  34.  Jun 7

    More

    Aviva Lev-Ari Retweeted Vanitha Sekar

    made by Bill & Melinda Gates Medical Research Institution most nobel cause

    Aviva Lev-Ari added,

    Fireside chat at with Sue Desmond-Hellmann, Susan Windham-Bannister & Penny Heaton about the Bill & Melinda Gates Medical Research Institution & their aim to translate innovative discoveries into solutions to…
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  35.  Jun 7

    More

    Aviva Lev-Ari Retweeted HLC

    in Medicine

    Aviva Lev-Ari added,

    RT : See how we’re using tools used in facial recognition to speed up .
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  36.  Jun 7

    More

    Aviva Lev-Ari Retweeted BlueCloud

    BRAVO Argentine

    Aviva Lev-Ari added,

    Our 1st and we had a blast! The experience was so unique and promising. Let’s create a better world, together.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  37.  Jun 7

    More

    Aviva Lev-Ari Retweeted NFIA North America

    BRAVO Holland! places Holland No. 1 in the world for medical technology patents!

    Aviva Lev-Ari added,

    The ’ world-class and highly collaborative sector places Holland No. 1 in the world for medical technology patents. Learn more about healthcare innovation: …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity